Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Giovanni C Actis"'
Autor:
Giovanni C Actis, Davide G Ribaldone
Publikováno v:
Qeios.
SARS-CoV2 and its syndromic tail, (soon become popular under the label -19), have now happily come of age after a glorious rush (though frankly destructive for us) around the world, after pulling out of the stinky shuffle of a poorly identified Chine
Autor:
Giovanni C Actis, Davide G Ribaldone
Publikováno v:
Qeios.
Some two years ago, a that far untold plague fell onto our heads without notice. Presenting initially with a harsh pneumonia destroying lung alveoli, SARS COVID 2 (SCVID2) reached rapidly the feat to kill over 80% of the older sick people in retireme
The human gut is an intensively colonized organ containing microorganisms that can be health-promoting or pathogenic. This feature led to the development of functional foods aiming to fortify the former category at the expense of the latter. Since lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4370c9518b63ef091b9b8647da4133a1
https://hdl.handle.net/2318/1894694
https://hdl.handle.net/2318/1894694
Autor:
Giovanni C Actis, Davide G Ribaldone
Publikováno v:
Qeios.
Some two years ago, a that far untold plague fell onto our heads without notice. Presenting initially with a harsh pneumonia destroying lung alveoli, SARS COVID 2 (SCVID2) reached rapidly the feat to kill over 80% of the older sick people in retireme
Autor:
Giovanni C. Actis
Publikováno v:
Minerva Gastroenterology. 68
Publikováno v:
Minerva Medica. 112
Publikováno v:
Clinical and Experimental Gastroenterology. 12:321-329
Western populations harbor a chronic inflammation pattern that lacks organ cardinal signs (edema, increased temperature, pain, and impaired function), releases increased levels of C-reactive protein, and often runs a creeping clinical course with gen
Publikováno v:
Reviews on Recent Clinical Trials. 14:4-9
Background:The need for immune suppressive strategies in the control of chronic inflammatory bowel diseases originated in the 1960s following the perception of a relative inefficacy of salazopyrin and its derivatives. In some 50 years upon an anecdot
The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b275031bcbb3c5ee10ca4fa96fe560
http://hdl.handle.net/2318/1777998
http://hdl.handle.net/2318/1777998
Publikováno v:
Gazzetta Medica Italiana Archivio per le Scienze Mediche. 179